Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
INDUSTRY SPONSOR REGULATORY BINDER DOCUMENTS TO BE MAINTAINED: COPIES OF THE FOLLOWING SHOULD BE RETAINED IN FILE OR MAINTAINED ELECTRONICALLY IN MYIRB SYSTEM CURRICULUM VITAES FOR THE PRINCIPAL INVESTIGATOR AND ALL PHYSICIAN SUBINVESTIGATORS LISTED ON THE FORM FDA 1572. THESE MUST BE CURRENT (LESS THAN TWO YEARS OLD). CURRICULUM VITAES FOR ALL RESEARCH COORDINATORS AND RESEARCH NURSES INVOLVED IN THE STUDY (LESS THAN TWO YEARS OLD) CURRENT MEDICAL LICENSES FOR THE RESEARCH STAFF (ALL APPLICABLE): Principal Investigator (if MD) Co-Investigators (if MDs, nurses, etc) All others, ex: PTs, RTs, RRTs, RPh COMPLETED AND SIGNED FORM FDA 1572 Send original to Sponsor Retain copy in file PROTOCOL SIGNATURE PAGE Send original to Sponsor Retain copy in file INVESTIGATOR BROCHURE Send signed acknowledgement of receipt to Sponsor Retain copy in file LABORATORY CERTIFICATIONS AND NORMAL REFERENCE RANGES Local Laboratory CAP/CLIA Certifications Director CV and license Normal Reference Ranges Updated Lab information Retain copy in file IRB INITIAL SUBMISSION APPLICATION Feb. 2014 INDUSTRY SPONSOR REGULATORY BINDER FOLLOW INSTRUCTIONS PER MYIRB AND SUBMIT APPLICABLE DOCUMENTS Current Version of Protocol (with version number and date) Completed IRB Application Consent Form (with version number and date in footer) Include all versions – short forms, verbal scripts, assents, consents All data collection instruments relevant to study All other information administered/provided to subjects; e.g: diaries, questionnaires Certificate of Confidentiality, if required IRB CORRESPONDENCE PI Correspondence Report Form Approval Memo and supporting documentation (i.e. Waiver of HIPAA Authorization) STUDY COMMUNICATION Date of conversation Name of people engaged in this conversation & affiliation Include brief description of conversation Means: email, phone, person to person, fax If applicable: copy of email Note: any follow-up required (by CRC/PI) File correspondence in appropriate location, e.g.: subject record or regulatory binder, appropriate section DURING THE CLINICAL TRIAL IRB MODIFICATION UPDATE FORM Submit and Maintain Modification Update Form Approval Memo and supporting documentation REPORTABLE EVENT FORM Submit and Maintain Reportable Event Form Maintain and file Study specific event report form(s): IND Safety Reports; Med Watch Forms, if applicable STUDY RECRUITMENT ALL STUDY RECRUITMENT MATERIALS NEED TO BE SUBMITTED TO IRB Feb. 2014 INDUSTRY SPONSOR REGULATORY BINDER E.g. Advertisements, press releases, letters to colleagues, letter to participants IRB CONTINUING REVIEW FOLLOW INSTRUCTIONS PER MYIRB AND SUBMIT APPLICABLE DOCUMENTS Complete myIRB Continuing Review Form END OF STUDY FORMS PROJECT CLOSE FORM FOLLOW INSTRUCTIONS PER MYIRB AND SUBMIT APPLICABLE DOCUMENTS Submit and Maintain Project Close Form CONSIDER THE FOLLOWING DOCUMENTATION FORMS FOR DATA COLLECTION Inclusion/Exclusion check off Case report forms Copy of Note-to-File to be used Screening log Enrollment log Master ID list: Code linking participant with a subject ID Shipping log of Investigational Product Receipt log of Investigational Product Temperature log Dispensing log of Investigational Product REMINDER: KEEP CURRENT STUDY DOCUMENTS E.G. Laboratory Certification/Accreditation/Values; CVs, License Feb. 2014 INDUSTRY SPONSOR REGULATORY BINDER Feb. 2014